Showing results (381-390 of 408) with videos related to

Sort By:
Pageof 41
The European Respiratory Journal|April 7, 2004
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliteransA T Iacono, T E Corcoran, B P Griffith, et al.
Peptides|July 1, 1993
Enhanced antiopiate activity and enzyme resistance in peptidomimetics of FMRFamide containing (E)-2,3-methanomethionineD H Malin, J R Lake, K Payza, et al.
The New England Journal of Medicine|April 27, 1995
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's diseaseJ H Kordower, T B Freeman, B J Snow, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 25, 2001
Potential role for P-glycoprotein in the non-proportional pharmacokinetics of UK-343,664 in manS Abel, K C Beaumont, C L Crespi, et al.
Annals of Neurology|September 1, 1995
Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's diseaseT B Freeman, C W Olanow, R A Hauser, et al.
Peptides|January 1, 1996
Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FFD H Malin, J R Lake, J A Jones, et al.
Scientific Reports|July 8, 2024
Compound osteoderms preserved in amber reveal the oldest known skinkJuan D Daza, Edward L Stanley, Matthew P Heinicke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecanR S Midgley, D J Kerr, K T Flaherty, et al.
International Journal of Clinical Pharmacology and Therapeutics|March 14, 2009
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumorsR L Oostendorp, J Loftiss, S Goel, et al.
British Journal of Cancer|August 21, 2015
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumoursB Milojkovic Kerklaan, M P J Lolkema, L A Devriese, et al.
Pageof 41